Sign in

CIK 0001775194

  • Non-accelerated filer
  • Smaller reporting company

UPEXI, INC.

Sign in to watch
Ticker
UPXI
Exchange
Nasdaq
Industry
Finance Services
FY end
Jun 30
Incorporated
DE
Entity type
Operating
EIN
833378978
Phone
+1 727-287-2800
Business address
3030 N. ROCKY POINT DRIVE, SUITE 420, TAMPA, FL
Former names
GROVE, INC.
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$0
in 0 filings

Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Date Insider Transaction Shares Price Value Owned after
2026-07-03 Salkind Gene Director Grant or award +100,000 318,750
2025-11-20 Salkind Gene Director Purchase +50,000 $2.55 $128K 218,750
2025-11-17 Salkind Gene Director Purchase +100,000 $2.65 $265K 569,470
2025-11-17 Salkind Gene Director Purchase +100,000 $2.81 $281K 168,750
2025-07-16 Salkind Gene Director Grant or award +50,000 435,370
2025-07-16 Salkind Gene Director Grant or award +150,000 585,370
2025-07-11 Salkind Gene Director Purchase +20,243 $4.94 $100K 385,370
2025-04-17 Salkind Gene Director Purchase +241,229 $2.28 $550K 365,127
2025-04-17 Salkind Gene Director Grant or award · Options to buy common stock +35,000 35,000
2025-01-17 Salkind Gene Director Grant or award · Options to buy common stock +25,000 25,000
2022-09-30 Salkind Gene Director Grant or award · Stock Option Grant (right to buy) +50,000 50,000
2022-03-30 Salkind Gene Director Purchase +125,000 $4.00 $500K 125,000
2021-07-21 Salkind Gene Director Grant or award · Option Grant +50,000 50,000

Page 1 of 1 · 13 trades